AnaBios Corporation, Inc., a San Diego, CA-based contract research organization that deploys assays and develops databases for the assessment of efficacy and safety of drugs, has raised $800k in Series A financing.
Investors include the Tech Coast Angels and the Angel Capital Entrepreneur (ACE) Fund.
The company, which intends to raise up to $2m, will use the capital to fund its new laboratory facility in San Diego.
Led by CEO and Chairman Dr. Jack A. Reynolds, of AnaBios Corporation will deploy assays and develop databases for the testing of efficacy and safety of drugs in development. Its platform will provide relevant data in advance of clinical trials, further enabling decision making concerning compound selection, dosing, risk mitigation and management.